Logo image of ALSRS.PA

SIRIUS MEDIA (ALSRS.PA) Stock Fundamental Analysis

Europe - EPA:ALSRS - FR0010812230 - Common Stock

0.0015 EUR
0 (0%)
Last: 10/22/2025, 7:00:00 PM
Fundamental Rating

0

Overall ALSRS gets a fundamental rating of 0 out of 10. We evaluated ALSRS against 63 industry peers in the Media industry. Both the profitability and financial health of ALSRS have multiple concerns. ALSRS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALSRS has reported negative net income.
ALSRS had a positive operating cash flow in the past year.
In the past 5 years ALSRS reported 4 times negative net income.
ALSRS had a positive operating cash flow in 4 of the past 5 years.
ALSRS.PA Yearly Net Income VS EBIT VS OCF VS FCFALSRS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

1.2 Ratios

ALSRS has a Return On Assets of -4.96%. This is in the lower half of the industry: ALSRS underperforms 77.42% of its industry peers.
Industry RankSector Rank
ROA -4.96%
ROE N/A
ROIC N/A
ROA(3y)-3.7%
ROA(5y)-7.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSRS.PA Yearly ROA, ROE, ROICALSRS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 100 -100 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALSRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALSRS.PA Yearly Profit, Operating, Gross MarginsALSRS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

0

2. Health

2.1 Basic Checks

ALSRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALSRS has been increased compared to 1 year ago.
ALSRS has more shares outstanding than it did 5 years ago.
ALSRS has a worse debt/assets ratio than last year.
ALSRS.PA Yearly Shares OutstandingALSRS.PA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ALSRS.PA Yearly Total Debt VS Total AssetsALSRS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -1.12, we must say that ALSRS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.12, ALSRS is doing worse than 90.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACCN/A
WACC4.43%
ALSRS.PA Yearly LT Debt VS Equity VS FCFALSRS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M 20M

2.3 Liquidity

ALSRS has a Current Ratio of 0.21. This is a bad value and indicates that ALSRS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.21, ALSRS is doing worse than 95.16% of the companies in the same industry.
ALSRS has a Quick Ratio of 0.21. This is a bad value and indicates that ALSRS is not financially healthy enough and could expect problems in meeting its short term obligations.
ALSRS has a worse Quick ratio (0.21) than 95.16% of its industry peers.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.21
ALSRS.PA Yearly Current Assets VS Current LiabilitesALSRS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M

0

3. Growth

3.1 Past

ALSRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -478.00%.
ALSRS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -61.40%.
Measured over the past years, ALSRS shows a decrease in Revenue. The Revenue has been decreasing by -3.64% on average per year.
EPS 1Y (TTM)-478%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.7%
Revenue 1Y (TTM)-61.4%
Revenue growth 3Y0.68%
Revenue growth 5Y-3.64%
Sales Q2Q%-97.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALSRS.PA Yearly Revenue VS EstimatesALSRS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ALSRS.PA Yearly EPS VS EstimatesALSRS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 -0.02 -0.04 -0.06 -0.08 -0.1

0

4. Valuation

4.1 Price/Earnings Ratio

ALSRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSRS.PA Price Earnings VS Forward Price EarningsALSRS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.16
ALSRS.PA Per share dataALSRS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALSRS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SIRIUS MEDIA

EPA:ALSRS (10/22/2025, 7:00:00 PM)

0.0015

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.66M
Revenue(TTM)6.73M
Net Income(TTM)-4387000
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF 0.46
P/B N/A
P/tB N/A
EV/EBITDA -0.16
EPS(TTM)-0.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFY216.46%
SpS0.01
BVpS0
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.96%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.7%
ROA(5y)-7.74%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.88
Cap/Depr 103.2%
Cap/Sales 170.32%
Interest Coverage N/A
Cash Conversion 70.01%
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.21
Altman-Z -1.12
F-Score2
WACC4.43%
ROIC/WACCN/A
Cap/Depr(3y)61.89%
Cap/Depr(5y)77.86%
Cap/Sales(3y)32.81%
Cap/Sales(5y)21.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-478%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.4%
Revenue growth 3Y0.68%
Revenue growth 5Y-3.64%
Sales Q2Q%-97.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-159%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-510.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y458.5%
OCF growth 3Y83.12%
OCF growth 5Y47.5%